Humacyte Inc (HUMA)
Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium)
MiMedx Group Inc (MDXG)
MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial
Humacyte Inc (HUMAW)
Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium)
MeiraGTx Holding (MGTX)
MeiraGTx Reports Third Quarter 2025 Financial and Operational Results
Vivani Medical Inc. (VANI)
Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results
Imunon Inc (IMNN)
IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update
Cognition Therapeutics Inc. (CGTX)
Cognition Therapeutics Completes Enrollment in Phase 2 Study of Zervimesine (CT1812) in Early Alzheimer’s Disease
DocGo Inc (DCGO)
DocGo Announces Participation at Upcoming Investor Conferences
Palatin Technologies Inc. (PTN)
A New Press Release from Palatin Technologies, Inc.
LAVA Therapeutics N.V. (LVTX)
LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq